CORT Q1 2021 Earnings — Corcept Therapeutics Incorporated Revenue & Financial Results | Market Cap Arena

CORTCorcept Therapeutics Incorporated

$4B

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$79M-14.8% YoY

Gross Profit

$78M98.4% margin

Operating Income

$20M24.7% margin

Net Income

$23M29.5% margin

EPS (Diluted)

$0.18

QoQ Revenue Growth

-7.3%

Cash Flow

Operating Cash Flow

$25M

Free Cash Flow

$25M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$552M

Total Liabilities

$42M

Stockholders' Equity

$511M

Cash & Equivalents

$52M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$79M	$93M	-14.8%
Gross Profit	$78M	$91M	-14.4%
Operating Income	$20M	$38M	-47.9%
Net Income	$23M	$30M	-22.0%